Advancement of nanomedicines in chronic inflammatory disorders
Crossref DOI link: https://doi.org/10.1007/s10787-022-00927-x
Published Online: 2022-02-25
Published Print: 2022-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jogpal, Vikas
Sanduja, Mohit
Dutt, Rohit
Garg, Vandana
Tinku, http://orcid.org/0000-0002-8254-0400
Text and Data Mining valid from 2022-02-25
Version of Record valid from 2022-02-25
Article History
Received: 31 December 2021
Accepted: 18 January 2022
First Online: 25 February 2022
Declarations
:
: All authors declare no conflict of interest.
Free to read: This content has been made available to all.